Product NDC: | 0338-1019 |
Proprietary Name: | NAFCILLIN |
Non Proprietary Name: | NAFCILLIN |
Active Ingredient(s): | 2 g/100mL & nbsp; NAFCILLIN |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0338-1019 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050655 |
Marketing Category: | NDA |
Start Marketing Date: | 19891031 |
Package NDC: | 0338-1019-48 |
Package Description: | 100 mL in 1 BAG (0338-1019-48) |
NDC Code | 0338-1019-48 |
Proprietary Name | NAFCILLIN |
Package Description | 100 mL in 1 BAG (0338-1019-48) |
Product NDC | 0338-1019 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | NAFCILLIN |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19891031 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | NAFCILLIN SODIUM |
Strength Number | 2 |
Strength Unit | g/100mL |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |